# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Jim Cramer has highlighted the potential benefits for U.S. automakers, particularly Ford and General Motors, following the Bide...
- Reuters
Barclays analyst Travis Steed maintains Becton Dickinson (NYSE:BDX) with a Overweight and raises the price target from $305 ...
BD reports Q2 sales of $5.04 billion, up 4.6% Y/Y. BD Medical, Life Sciences, and Interventional segments show growth. Guidance...
Becton, Dickinson (NYSE:BDX) reported quarterly earnings of $3.17 per share which beat the analyst consensus estimate of $2.97 ...
The new BD FACSDiscover S8 Cell Sorters feature BD CellView Image Technology, profiled on the cover of the journal Science in 2...